FARS2 expression was substantially downregulated in HF and cardiomyopathies, including HCM (Figure S6), demonstrating that FARS2 deficiency may be the pathogenic mechanism of cardiomyopathies and HF. Here, FARS2 is linked to cardiomyopathy.